The Competition Commission of India (CCI) has raised concerns about the pricing practices of private super-speciality hospitals in Delhi-NCR, particularly regarding the dependency of patients on hospital-run pharmacies and diagnostic services. This dependency can lead to inflated costs, as patients often have limited options for cheaper alternatives outside the hospital. The investigation, which began with a complaint in 2015 about inflated syringe prices, examined pricing trends at Sir Ganga Ram Hospital and found that many diagnostic tests were significantly more expensive than those offered by standalone facilities. For instance, certain imaging services were reported to be over 50% pricier than their counterparts. Despite these findings, the CCI ultimately closed proceedings against Sir Ganga Ram Hospital, citing insufficient evidence to prove any abuse of market dominance. The hospital defended its pricing model, stating that it operates under a charitable trust, using revenue from paying patients to subsidize care for economically disadvantaged individuals. The CCI acknowledged the operational costs associated with hospital-run services but emphasized that procurement costs alone cannot determine pricing fairness.